Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO 11712-14:2019 specifies requirements for anti-reflux mechanisms integrated into disposable and reusable suction and drainage bags used in anaesthetic and respiratory equipment. This part of the ISO 11712 standard covers design characteristics, performance testing, and biocompatibility requirements for components intended to prevent retrograde flow of fluids and airborne contaminants into the patient’s anatomy. It applies to bags used in vacuum drainage systems within hospital environments, including those used for postoperative drainage, urine collection, and thoracic drainage. The standard complements existing requirements of ISO 11712 and extends safety by addressing the prevention of cross-contamination and backflow during clinical use.
All materials in contact with body fluids must comply with ISO 10993 series for biological evaluation. The anti-reflux valve shall be manufactured from materials resistant to cracking, delamination, and leakage after repeated exposure to vacuum cycles typically encountered in clinical use. If the device incorporates a duckbill or flap valve, the elastomer must demonstrate fatigue resistance over its intended lifetime.
| Parameter | Requirement | Test Method |
|---|---|---|
| Cracking pressure | ≤ 5 cm H₂O (≤ 490 Pa) | ISO 11712-14 Annex A — slow pressurization at inlet |
| Backflow leakage (fluid) | ≤ 0.2 mL under 100 cm H₂O back pressure | ISO 11712-14 Annex B — static head test |
| Backflow leakage (air) | ≤ 5 mL/min at 50 cm H₂O differential | ISO 11712-14 Annex C — pneumatics circuit |
| Durability | ≥ 500 open/close cycles without failure | Automated cycling with simulated drainage fluid |
The anti-reflux mechanism must be designed to integrate with connectors complying with ISO 594‑1 for luer slip and luer lock interfaces. The internal geometry of the valve housing shall minimise eddy currents that could trap sediments and impair valve closure. The cracking pressure requirement ensures that the valve opens readily under normal drainage conditions (e.g., a full urinary bladder at low pressure) but prevents unintended backflow during repositioning or reversal of gravitational head.
Manufacturers integrating anti-reflux mechanisms into existing drainage bag designs should validate cracking pressure across the full range of intended operating temperatures (15 °C to 40 °C). The standard recommends that the valve be positioned as close to the patient connection as possible to minimise dead volume. Sterilisation compatibility is critical: products labelled as sterile must undergo validation per ISO 11135 (EtO) or ISO 11137 (radiation) without compromising the anti-reflux function.
Conformity with ISO 11712-14:2019 requires a documented quality management system (ISO 13485) and a technical file that includes: (1) biocompatibility test reports; (2) performance test results according to the annexes; (3) stability data for the anti-reflux mechanism under accelerated aging; and (4) risk management per ISO 14971. Notified bodies auditing for the Medical Device Regulation (EU) 2017/745 consider the anti-reflux function as a critical safety feature. The standard does not mandate a specific design but sets measurable performance thresholds that must be met.
Annual recertification is recommended to verify that materials and production processes remain within validated tolerances. For existing products originally qualified to earlier editions, a gap analysis against this 2019 version is essential. Some major markets (e.g., Japan, MHLW; USA, FDA guidance) reference this standard as a recognised consensus document for submission of 510(k) premarket notifications.